Skip to main content

ResearchResearch summary

How patients and clinicians experience recurrent-thrush diagnosis

Interviews in England describe recurrence documentation, test access, result interpretation, and diagnostic labeling as a connected pathway.

In this pathway

Current topic
How patients and clinicians experience recurrent-thrush diagnosisCurrent

Page trust and updates

First published
2026-07-15
Evidence as of
2026-07-15
Last updated
2026-07-15
Authorship
Candipedia Research
What changed
Initial draft summary created from the selected source.
Mogana Das Murtey and Patchamuthu Ramasamy, "Saccharomyces cerevisiae, SEM image", licensed under CC BY 3.0

Bottom line

Patients and professionals described recurrent-thrush diagnosis as a multi-step pathway, not a single test or symptom judgment.

Why this source matters

It explains why documenting episode patterns, gaining access to testing, and interpreting results can shape a person's route through care.

Study and population

Researchers interviewed 32 self-identifying patients and 25 primary-care or sexual-health professionals in England.

What was tested

The study explored experiences and perceptions through interviews; it did not test a diagnostic method, treatment, or history tool.

Results

The thematic analysis connected pattern recognition, recurrence documentation, service access, test interpretation, and diagnostic labeling. It produced no numerical estimate of diagnostic or clinical effectiveness.

Applicability

The findings help explain English care experiences and support preparing a structured history. They do not describe access in every health system.

Limitations

Patients self-identified as having recurrent thrush, accounts were collected in England, and qualitative findings cannot establish diagnostic accuracy or outcome benefit.

Contribution to the evidence

Contextual. The interviews clarify how people navigate diagnosis but do not test whether any pathway improves clinical outcomes.

Practical change

No practical change. The study supports careful documentation and interpretation, not self-diagnosis or a treatment choice.

Funding and conflicts

Funding and conflicts of interest were not reported in the canonical source record.

Source

Read the original publication (published 1 June 2026).

Study type, population, and sample scale

Study type
Qualitative interview study with reflexive thematic analysis and Candidacy Framework interpretation
Population
32 people who self-identified as having recurrent thrush and 25 healthcare professionals working in primary care and sexual health services in England
Sample scale
57 interview participants (32 patients; 25 professionals)
Read the original source

Results

  • Interviews with all 32 patient participants and 25 professionals identified diagnosis as a process involving recognition and documentation of recurrence, access to testing, interpretation of results, and a diagnostic label that opened management pathways.
  • The analysis described differing expectations and understandings as perceived missed opportunities across five Candidacy Framework stages; qualitative interviews do not provide a numerical effectiveness estimate.

Limitations

Participants described documentation, testing access, interpretation, and labeling as connected parts of diagnosis.
Self-identifying patient recruitment and qualitative analysis cannot measure diagnostic accuracy or treatment outcomes.
Patient and professional accounts exposed barriers and differing expectations.
The England setting does not establish the same service barriers in other health systems.

Applies to

  • Understanding patient and professional experiences of recurrent-thrush diagnostic pathways in English primary care and sexual health services

Does not apply to

  • Clinical effectiveness of a history tool, diagnostic accuracy, or access to testing outside England

Contribution to the current conclusion

Contextual

This current qualitative study of 32 self-identifying patients and 25 professionals materially explains why recurrence documentation, testing access, and interpretation matter, while a summary can make its UK setting and inability to establish clinical effectiveness explicit.

Related evidence map

Practical change or no change

No practical change. The study informs history and appointment preparation but cannot establish diagnosis or prove that a tool improves outcomes.

Funding and conflicts

Funding
Funding not reported.
Conflicts
Conflicts of interest not reported.
Paper date
2026-06-01

Sources

View all 1 source